{"disease":{"id":"specific-phobias","name":"specific phobias"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02605668","title":"Providing Tools for Effective Care and Treatment of Anxiety Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":726,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT03095482","title":"tDCS-Augmented Exposure Therapy for Pathological Fear","phase":"NA","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT06906770","title":"Virtual Reality-based Eye Movement Desensitisation and Reprocessing Therapy for Specific Phobias","phase":"NA","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"The University of Northampton","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}